Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
Lead investor confirmed his intention to maintain his current shareholdings.Company does not…
Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings…
Tevogen Recognized in BINJEs BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc.…
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from…
REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings…
